Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Atomoxetine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atomoxetine 40mg capsules
0404000S0AAABAB
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 12,221 |
|
Atomoxetine 80mg capsules
0404000S0AAAFAF
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 8,842 |
|
Atomoxetine 60mg capsules
0404000S0AAAEAE
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 8,727 |
|
Atomoxetine 25mg capsules
0404000S0AAADAD
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 7,129 |
|
Atomoxetine 10mg capsules
0404000S0AAAAAA
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 6,302 |
|
Atomoxetine 18mg capsules
0404000S0AAACAC
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 3,546 |
|
Atomoxetine 100mg capsules
0404000S0AAAHAH
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 3,428 |
|
Atomoxetine 4mg/ml oral solution sugar free
0404000S0AAAKAK
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 1,043 |
|
Atomoxetine 25mg/5ml oral liquid
0404000S0AAAIAI
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 27 |
|
Atomoxetine 20mg/5ml oral suspension
0404000S0AAALAL
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 2 |
|
Atomoxetine 10mg/5ml oral solution
0404000S0AAARAR
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 1 |
|
Atomoxetine 30mg/5ml oral suspension
0404000S0AAAPAP
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 36mg/5ml oral suspension
0404000S0AAAQAQ
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 40mg/5ml oral suspension
0404000S0AAAJAJ
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 5mg/5ml oral solution
0404000S0AAAGAG
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 5mg/5ml oral suspension
0404000S0AAAMAM
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 60mg/5ml oral solution
0404000S0AAANAN
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.